New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MRK;PFE;GSK;JNJ;BMY;NVS;SHPG;ABT;CELG;SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
October 28, 2014
10:23 EDTPFEPfizer says still looking at deals based on strategic fit
Pfizer (PFE) said during its earnings conference call that uncertainty around future tax actions remain a concern, but that the company is still looking for M&A opportunities. Pfizer says proposed rule changes have made "inversions" more difficult, but that meaningful value from inversion deals can still exists on a "case-by-case" basis. Shares of AstraZeneca (AZN), which was previously a target of Pfizer, are up 1.3% to $71.69 as Pfizer's earnings conference call continues.
09:37 EDTMRKActive equity options trading
Subscribe for More Information
09:34 EDTCELGCelgene management to meet with Leerink
Subscribe for More Information
09:20 EDTSNYOn The Fly: Pre-market Movers
Subscribe for More Information
07:50 EDTABTAbbott management to meet with Deutsche Bank
Subscribe for More Information
07:50 EDTCELGCelgene added to US 1 List at BofA/Merrill
Subscribe for More Information
07:35 EDTPFEDURECT price target liowered to $1.50 from $2.50 at Stifel
Subscribe for More Information
07:31 EDTNVSThe FDA to hold a workshop
First Annual Neonatal Scientific Workshop, "Roadmap for Applying Regulatory Science to Neonates" is being held at FDA Silver Spring, Maryland offices on October 28-29 at 8:30 am. Webcast Link
07:27 EDTMRKFDA PDUFA Date for Merck's MK-3475 is October 28, 2014
Subscribe for More Information
07:24 EDTCELGCelgene added to US 1 List at BofA/Merrill
07:21 EDTJNJCBI to hold a conference
Subscribe for More Information
07:16 EDTMRKInvestors overlooking Merck positive points, says SunTrust
Subscribe for More Information
07:06 EDTPFEPfizer reports Q3 GEP sales down 6% operationally, GIP sales down 4%
Subscribe for More Information
07:05 EDTPFEPfizer narrows FY14 adjused EPS view to $2.23-$2.27 from $2.20-$2.30
Subscribe for More Information
07:04 EDTBMYBristol-Myers enters agreement to acquire F-star Alpha, rights to FS102
Subscribe for More Information
07:03 EDTBMYBristol-Myers enters agreement to acquire F-star Alpha, rights to FS102
07:01 EDTPFEPfizer reports Q3 adjusted EPS 57c, consensus 55c
Subscribe for More Information
05:40 EDTSNYSanofi reports Q3 business EPS EUR 1.47 vs. EUR 1.36 last year
Subscribe for More Information
05:35 EDTNVSNovartis confirms FY14 revenue view of growth at a low to mid-single digit rate
Subscribe for More Information
05:31 EDTNVSNovartis reports Q3 core EPS $1.37, consensus $1.29
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use